2016 -2017 Senior Analyst, Marketing Analytics and Consulting @
2014 -2016 Business Insight Analyst @
2012 -2014 Associate Health Economist @
2011 -2012 Health Outcomes Associate @
2009 -2010 Health Outcomes Analyst @
2008 -2008 Research associate @
2007 -2007 Research analyst @
2007 -2007 Research Assistant @ Makerere University, Molecular Research Laboratory, University of California (Ug
Tessa Angle Education
UCLA Anderson School of Management
Women in Governance Certificate
2024
Imperial College London
Columbia University
Choate Rosemary Hall
Lycée Français de San Francisco
San Francisco University High School
Tessa Angle Skills
Health Economics
HTA
Outcomes Research
Pharmacoeconomics
Market Access
Evidence-based Medicine
Pharmaceutical Industry
Epidemiology
Clinical Trials
Oncology
Health Services Research
Immunology
Infectious Diseases
Medical Writing
Diabetes
Sales Effectiveness
Clinical Development
Strategy
Medical Affairs
Clinical Research
Medical Devices
Neurology
Pharmacovigilance
Cardiology
Drug Development
Neuroscience
Pharmaceutical Sales
Pharmaceutics
Hospital Sales
Vaccines
Lifesciences
Healthcare
Research
Evidence Based Medicine
Tessa Angle Summary
Tessa Angle, based in Los Angeles, CA, US, is currently a Chief Customer Officer at RxPx. Tessa Angle brings experience from previous roles at Healthcare Businesswomen’s Association, and RxMx. Tessa Angle holds a Women in Governance Certificate @ UCLA Anderson School of Management. With a robust skill set that includes Health Economics, HTA, Outcomes Research, Pharmacoeconomics, Market Access and more. Tessa Angle has 3 emails and 7 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.